Drug intelligence / Profile preview

Yuyang Capsule

Development stage: Preclinical
Lead developer: Chinese Medicine Bureau of Sichuan Province
Administration: Oral

Overview

Yuyang Capsule is a Traditional Chinese Medicine (TCM) formulation developed by the Sichuan Provincial Administration of Traditional Chinese Medicine. It is primarily investigated for its potential to promote immune reconstitution and delay the progression of AIDS in HIV-infected patients when used in combination with Highly Active Antiretroviral Therapy (HAART). The capsule is intended to support the immune system, specifically targeting the recovery of CD4+ T-cell counts in patients who exhibit poor immune response despite viral suppression.

Brand names: Yuyang Capsule
Other names: Yuyang

Beyond the preview

Go deeper on Yuyang Capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yuyang Capsule.

Explore the full profile